Bal Pharma has informed that the meeting of Board of Directors of the Company is scheduled to be held on 11th August 2022 on Thursday to take on record and approve the Unaudited financial results of the Company for the quarter ended 30.06.2022. Further, pursuant to amended provisions of SEBI (Prohibition of Insider Trading Regulations),2015 and as per the provisions of Code of Conduct of the Company, the trading window for dealing in securities of the Company by its designated persons/employees and their ‘immediate relatives was closed from 01.07.2022 up to 14.08.2022 48 hours after declaration of financial results of the Company for the quarter ended 30.06.2022.
The above information is a part of company’s filings submitted to BSE.
